Showing 16 of 6

Page 1 of 1

Expectedness vs Unexpectedness explained in Pharmacovigilance

“Expectedness vs Unexpectedness explained” is a fundamental concept in pharmacovigilance that determines regulatory reporting obligations and influences signal detection and risk management. Accurate classification of adverse events as expected or unexpected ensures compliance with global guidelines and strengthens drug safety evaluation.

Pharmacovigilance-topics

Follow-up queries: how to ask the right questions (Pharmacovigilance)

“Follow-up queries: how to ask the right questions” is a critical competency in pharmacovigilance that directly impacts the quality of adverse event data, signal detection, and regulatory compliance. Effective follow-up questioning ensures completeness, accuracy, and clinical relevance of Individual Case Safety Reports (ICSRs) and supports robust drug safety evaluation.

Pharmacovigilance-topics

Valid case criteria explained (practical scenarios) in Pharmacovigilance

Valid case criteria explained (practical scenarios) is a foundational concept in pharmacovigilance that determines whether an adverse event report qualifies as a reportable Individual Case Safety Report (ICSR). Accurate identification ensures regulatory compliance, robust signal detection, and effective risk management in drug safety systems.

PharmacovigilanceTopics

Common mistakes in case triage in Pharmacovigilance

Common mistakes in case triage can significantly compromise drug safety, regulatory compliance, and signal detection processes. This article examines critical pitfalls in pharmacovigilance case triage and provides expert insights to enhance accuracy, efficiency, and compliance.

PharmacovigilanceTopics

Importance of Pharmacovigilance in Drug Safety

Pharmacovigilance plays a critical role in ensuring drug safety by monitoring, detecting, assessing, and preventing adverse effects associated with pharmaceutical products. This article explores the importance of pharmacovigilance in safeguarding public health, improving regulatory compliance, and enhancing the overall benefit-risk profile of medicines.

PharmacovigilanceTopics

FDA’s New Adverse Event Look-Up Tool: The Beginning of Real-Time Pharmacovigilance

The FDA’s launch of the Adverse Event Look-Up Tool under the Adverse Event Monitoring System (AEMS) represents a significant shift toward real-time, transparent, and data-driven pharmacovigilance. For pharmacovigilance teams, this development introduces both strategic opportunities and operational challenges, requiring a transition from traditional service models to advanced, insight-driven safety solutions.

USFDAPv-Updates